Modeling the relative impact of capsular tissue effects on implanted glucose sensor time lag and signal attenuation MT Novak, F Yuan, WM Reichert Analytical and bioanalytical chemistry 398, 1695-1705, 2010 | 76 | 2010 |
Systems, devices, and methods relating to medication dose guidance GA Hayter, A Bhattacharya, ES Budiman, MT Novak, T Jin, MB Taub, ... US Patent App. 16/944,736, 2021 | 28 | 2021 |
Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials MT Novak, JD Bryers, WM Reichert Biomaterials 30 (11), 1989-2005, 2009 | 25 | 2009 |
Response of monocytes exposed to phagocytosable particles and discs of comparable surface roughness DH Kim, MT Novak, J Wilkins, M Kim, A Sawyer, WM Reichert Biomaterials 28 (29), 4231-4239, 2007 | 25 | 2007 |
Predicting glucose sensor behavior in blood using transport modeling: relative impacts of protein biofouling and cellular metabolic effects. MT Novak, F Yuan, WM Reichert Journal of diabetes science and technology 7 (6), 1547-1560, 2013 | 22 | 2013 |
Diagnostic tools and technologies for infectious and non-communicable diseases in low-and-middle-income countries MT Novak, CN Kotanen, S Carrara, A Guiseppi-Elie, FG Moussy Health and Technology 3, 271-281, 2013 | 20 | 2013 |
Modeling the physiological factors affecting glucose sensor function in vivo MT Novak, WM Reichert Journal of Diabetes Science and Technology 9 (5), 993-998, 2015 | 18 | 2015 |
Macrophage embedded fibrin gels: An in vitro platform for assessing inflammation effects on implantable glucose sensors MT Novak, F Yuan, WM Reichert Biomaterials 35 (36), 9563-9572, 2014 | 17 | 2014 |
Dynamic Seeding of Perfusing Human Umbilical Vein Endothelial Cells (HUVECs) onto Dual-Function Cell Adhesion Ligands: Arg-Gly-Asp (RGD)− Streptavidin and Biotinylated Fibronectin CC Anamelechi, EC Clermont, MT Novak, WM Reichert Langmuir 25 (10), 5725-5730, 2009 | 10 | 2009 |
Modeling the Relative Effects of Biofouling, Fibrous Encapsulation and Microvessel Density on Implanted Glucose Sensor Performance MT Novak, F Yuan, WM Reichert Biophysical Journal 98 (3), 407a, 2010 | 2 | 2010 |
Systems and methods for diabetes management PA Kumar, K Hilton, JR Floeh, AM Revoltar, LC Swinehart, ... US Patent App. 17/725,063, 2022 | 1 | 2022 |
Impact of insulin excipients and infusion set wear time on insulin PK/PD R Pettis, L Hull, M Novak, A Harvey, D Morel, D Sutter, M Hompesch, ... DIABETES TECHNOLOGY & THERAPEUTICS 22, A193-A193, 2020 | 1 | 2020 |
Subcutaneous Bolus Administration of Meta-Cresol Decreases Insulin Absorption in a Swine Model MT Novak, K Riley, J Alarcon, A Harvey, R Pettis Diabetes Technology and Therapeutics 20 (S1), A140, 2018 | 1 | 2018 |
Systems and methods for diabetes management ES Budiman, MT Novak, GA Hayter US Patent App. 18/226,550, 2024 | | 2024 |
Filter for reducing phenolic compounds from insulin and related infusion and injection devices M Novak, AJ Harvey, DB Sherman, RJ Radford, J Alarcon, RJ Pettis, ... US Patent 11,672,907, 2023 | | 2023 |
Systems, devices, and methods relating to medication dose guidance GA Hayter, A Bhattacharya, ES Budiman, MT Novak, T Jin, MB Taub, ... US Patent App. 17/591,229, 2022 | | 2022 |
79-LB: The Effects of Glucose Reporting Tools on Therapeutic Decision Making—A Comparative Reading Study with Primary Care Providers MT Novak, G Hayter, E Wright, K Midyett, H Wolpert, N Virdi Diabetes 71 (Supplement_1), 2022 | | 2022 |
Delivery device and adsorbent M Novak, E Mainz, C Rini, B Roberts US Patent App. 17/050,321, 2021 | | 2021 |
Systems, devices, and methods relating to medication dose guidance GA Hayter, A Bhattacharya, ES Budiman, MT Novak, T Jin, MB Taub, ... US Patent US20210050085A1, 2021 | | 2021 |
Delivery device and adsorbent M Novak, E Mainz, C Rini, B Robert WO Patent App. 2019209644A1, 2019 | | 2019 |